| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| HumanPheno | Posteriorly rotated ears | 9.09e-05 | 470 | 10 | 6 | HP:0000358 | |
| HumanPheno | Slanting of the palpebral fissure | 1.06e-04 | 739 | 10 | 7 | HP:0200006 | |
| HumanPheno | Low-set ears | 1.28e-04 | 761 | 10 | 7 | HP:0000369 | |
| HumanPheno | Delayed speech and language development | 1.60e-04 | 1123 | 10 | 8 | HP:0000750 | |
| HumanPheno | Upslanted palpebral fissure | 2.22e-04 | 333 | 10 | 5 | HP:0000582 | |
| HumanPheno | Language impairment | 2.29e-04 | 1178 | 10 | 8 | HP:0002463 | |
| Domain | RCC1 | 2.72e-04 | 20 | 23 | 2 | PF00415 | |
| Domain | RCC1_3 | 3.00e-04 | 21 | 23 | 2 | PS50012 | |
| Domain | RCC1_1 | 3.00e-04 | 21 | 23 | 2 | PS00625 | |
| Domain | RCC1_2 | 3.00e-04 | 21 | 23 | 2 | PS00626 | |
| Domain | - | 3.00e-04 | 21 | 23 | 2 | 1.10.720.30 | |
| Domain | Reg_chr_condens | 3.30e-04 | 22 | 23 | 2 | IPR000408 | |
| Domain | SAP | 3.30e-04 | 22 | 23 | 2 | PF02037 | |
| Domain | - | 3.30e-04 | 22 | 23 | 2 | 2.130.10.30 | |
| Domain | SAP | 3.61e-04 | 23 | 23 | 2 | SM00513 | |
| Domain | RCC1/BLIP-II | 3.61e-04 | 23 | 23 | 2 | IPR009091 | |
| Domain | SAP | 4.28e-04 | 25 | 23 | 2 | PS50800 | |
| Domain | SAP_dom | 4.28e-04 | 25 | 23 | 2 | IPR003034 | |
| Domain | HECT | 5.00e-04 | 27 | 23 | 2 | PF00632 | |
| Domain | HECTc | 5.00e-04 | 27 | 23 | 2 | SM00119 | |
| Domain | HECT_dom | 5.00e-04 | 27 | 23 | 2 | IPR000569 | |
| Domain | HECT | 5.00e-04 | 27 | 23 | 2 | PS50237 | |
| Domain | Ubiquitin-rel_dom | 2.13e-02 | 184 | 23 | 2 | IPR029071 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 19077293 | ||
| Pubmed | Low SAFB levels are associated with worse outcome in breast cancer patients. | 5.37e-07 | 2 | 26 | 2 | 19137425 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 14587024 | ||
| Pubmed | SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells. | 5.37e-07 | 2 | 26 | 2 | 19901029 | |
| Pubmed | Unravelling the RNA-Binding Properties of SAFB Proteins in Breast Cancer Cells. | 5.37e-07 | 2 | 26 | 2 | 26273616 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 26092125 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 22566185 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 19674106 | ||
| Pubmed | SAFB1 interacts with and suppresses the transcriptional activity of p53. | 3.22e-06 | 4 | 26 | 2 | 21130767 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 16195251 | ||
| Pubmed | SAFB2, a new scaffold attachment factor homolog and estrogen receptor corepressor. | 3.22e-06 | 4 | 26 | 2 | 12660241 | |
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 9949213 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 1.62e-05 | 754 | 26 | 6 | 33060197 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.68e-05 | 759 | 26 | 6 | 35915203 | |
| Pubmed | 3.49e-05 | 251 | 26 | 4 | 28077445 | ||
| Pubmed | 5.65e-05 | 284 | 26 | 4 | 15057824 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 6.03e-05 | 954 | 26 | 6 | 36373674 | |
| Pubmed | 8.16e-05 | 18 | 26 | 2 | 20530870 | ||
| Pubmed | 8.63e-05 | 1497 | 26 | 7 | 31527615 | ||
| Pubmed | 1.22e-04 | 1084 | 26 | 6 | 11544199 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.25e-04 | 130 | 26 | 3 | 35545047 | |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 1.52e-04 | 139 | 26 | 3 | 25476789 | |
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 1.73e-04 | 26 | 26 | 2 | 26949039 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 1.86e-04 | 732 | 26 | 5 | 34732716 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 2.54e-04 | 420 | 26 | 4 | 28065597 | |
| Pubmed | GOLPH3 and GOLPH3L are broad-spectrum COPI adaptors for sorting into intra-Golgi transport vesicles. | 2.63e-04 | 32 | 26 | 2 | 34473204 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 2.78e-04 | 430 | 26 | 4 | 38172120 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 2.91e-04 | 807 | 26 | 5 | 22681889 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 3.18e-04 | 1294 | 26 | 6 | 30804502 | |
| Pubmed | 3.50e-04 | 457 | 26 | 4 | 22190034 | ||
| Pubmed | 3.64e-04 | 847 | 26 | 5 | 35850772 | ||
| Pubmed | 3.75e-04 | 189 | 26 | 3 | 31594818 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 4.04e-04 | 1353 | 26 | 6 | 29467282 | |
| Pubmed | 4.12e-04 | 40 | 26 | 2 | 12226475 | ||
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 4.87e-04 | 499 | 26 | 4 | 22810586 | |
| Pubmed | Identification of NPM-ALK interacting proteins by tandem mass spectrometry. | 5.69e-04 | 47 | 26 | 2 | 14968112 | |
| Pubmed | FIP200 controls the TBK1 activation threshold at SQSTM1/p62-positive condensates. | 6.06e-04 | 223 | 26 | 3 | 34226595 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 6.87e-04 | 1496 | 26 | 6 | 32877691 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 9.94e-04 | 797 | 26 | 4 | chr19p13 | |
| Cytoband | 17q21.31 | 9.96e-04 | 82 | 26 | 2 | 17q21.31 | |
| Cytoband | 19p13.3 | 7.95e-03 | 237 | 26 | 2 | 19p13.3 | |
| GeneFamily | RNA binding motif containing | 1.49e-02 | 213 | 16 | 2 | 725 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-06 | 192 | 26 | 4 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.56e-06 | 193 | 26 | 4 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| Computational | Neighborhood of TPR | 5.38e-05 | 147 | 16 | 4 | MORF_TPR | |
| Computational | Neighborhood of SS18 | 9.70e-05 | 62 | 16 | 3 | MORF_SS18 | |
| Computational | Neighborhood of PPP2R5E | 2.31e-04 | 83 | 16 | 3 | MORF_PPP2R5E | |
| Computational | Neighborhood of PPP5C | 3.04e-04 | 91 | 16 | 3 | MORF_PPP5C | |
| Computational | Neighborhood of CDC2L5 | 1.11e-03 | 142 | 16 | 3 | MORF_CDC2L5 | |
| Computational | Neighborhood of FANCG | 1.78e-03 | 167 | 16 | 3 | MORF_FANCG | |
| Drug | chlorotrianisene | 1.73e-06 | 21 | 26 | 3 | CID000011289 | |
| Drug | pSAP | 1.88e-05 | 6 | 26 | 2 | CID000007171 | |
| Drug | CI628M | 2.62e-05 | 7 | 26 | 2 | CID003035794 | |
| Drug | 4-hydroxyethynylestradiol | 3.50e-05 | 8 | 26 | 2 | CID000066396 | |
| Drug | U23,469 | 4.49e-05 | 9 | 26 | 2 | CID000161922 | |
| Drug | h EE | 5.61e-05 | 10 | 26 | 2 | CID000446896 | |
| Drug | coumestrol | 6.59e-05 | 69 | 26 | 3 | CID005281707 | |
| Drug | Thiamphenicol [15318-45-3]; Down 200; 11.2uM; HL60; HT_HG-U133A | 6.73e-05 | 195 | 26 | 4 | 1867_DN | |
| Drug | PHA-00816795 [212631-79-3]; Up 200; 10uM; PC3; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 7076_UP | |
| Drug | Niflumic acid [4394-00-7]; Down 200; 14.2uM; HL60; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 2399_DN | |
| Drug | ketononestrol aziridine | 9.71e-05 | 13 | 26 | 2 | CID000130642 | |
| Drug | 2-phenylindole | 9.71e-05 | 13 | 26 | 2 | CID000013698 | |
| Drug | DP-TAT-59 | 9.71e-05 | 13 | 26 | 2 | CID003037015 | |
| Drug | NSC35770 | 1.02e-04 | 80 | 26 | 3 | CID000002800 | |
| Drug | benzophenone-2 | 1.30e-04 | 15 | 26 | 2 | CID000008571 | |
| Drug | NSC98536 | 1.30e-04 | 15 | 26 | 2 | CID000004080 | |
| Drug | AC1Q7B2S | 1.30e-04 | 15 | 26 | 2 | CID000015019 | |
| Drug | alendronate | 1.45e-04 | 90 | 26 | 3 | CID000002088 | |
| Drug | TAT-59 | 1.49e-04 | 16 | 26 | 2 | CID003034829 | |
| Drug | OH-PCB 30 | 1.49e-04 | 16 | 26 | 2 | CID000105036 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 1.74e-05 | 194 | 24 | 4 | EFO_0004265, EFO_0007908 | |
| Disease | carnosine measurement | 1.73e-04 | 24 | 24 | 2 | EFO_0010470 | |
| Disease | coronary artery disease | 3.11e-04 | 1194 | 24 | 6 | EFO_0001645 | |
| Disease | fibroblast growth factor basic measurement | 1.05e-03 | 59 | 24 | 2 | EFO_0008130 | |
| Disease | nucleotide measurement | 1.61e-03 | 73 | 24 | 2 | EFO_0010513 | |
| Disease | sleep duration, triglyceride measurement | 3.23e-03 | 104 | 24 | 2 | EFO_0004530, EFO_0005271 | |
| Disease | Tinnitus | 4.99e-03 | 130 | 24 | 2 | HP_0000360 | |
| Disease | gestational age | 5.60e-03 | 138 | 24 | 2 | EFO_0005112 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MASWGGEKRGGAGGS | 1 | Q6NUI1 | |
| FGEAGAEWAGDKGGG | 761 | Q5TGY3 | |
| DTALGGGGGLSWAEK | 6 | Q14004 | |
| HTGGGGEKAAGGFRW | 26 | Q86YV0 | |
| GEKAAGGFRWGRFAG | 31 | Q86YV0 | |
| DGGGGGFGSWLDGRL | 16 | Q96MW1 | |
| LWTGGKDTCGGDSGG | 201 | P20151 | |
| SWGDGDFGKLGRGGS | 3176 | O95714 | |
| LAGGAGGGAGRKEDW | 31 | Q10471 | |
| SWGDGDYGKLGHGNS | 481 | Q15751 | |
| WSLGGRKGLGGSDGE | 1936 | Q9H6A9 | |
| DGGFPGLKWGGTHDG | 46 | Q86Y91 | |
| FGGGGGEFALWLDGD | 826 | Q8N573 | |
| GGLFKESWRGGGGDE | 876 | Q9P2Q2 | |
| RGGAGAGGGWKLAEE | 101 | Q92896 | |
| MWGSDRLAGAGGGGA | 1 | O43933 | |
| GDGKYGALRDGRWTG | 501 | O60391 | |
| WARGGAAGMAGAGAG | 11 | Q9NZJ7 | |
| KMGWTGGGLGKSGEG | 561 | O15226 | |
| RGGGRGNKHQGGWTD | 371 | Q8NCA5 | |
| GKRGRWSGGSGAGRG | 6 | Q8NCF5 | |
| GRDSRDGWGGYGSDK | 791 | Q15424 | |
| KKWGWETRGGFGGGG | 911 | Q9UM73 | |
| GAGGGGKLFSLCAWD | 176 | Q9NRU3 | |
| CWEKRGGAGGDTKGG | 71 | Q9P2C4 | |
| LGWKKSAGGSGGAGG | 16 | Q15796 | |
| GWGGYGSDKRLSEGR | 821 | Q14151 |